The EU General Court has reversed a ban on aloe vera preparations in food, initially implemented in March 2021, that affected botanical species containing hydroxyanthracene derivatives (HADs). The ban, prompted by a 2017 European Food Safety Authority (EFSA) scientific assessment, was challenged due to the European Commission's overreach in banning preparations rather than individual substances. Legal firm Covington & Burling's successful case argument hinged on the lack of consumer risk evidence from the EFSA assessment and the Commission's overstepping of regulatory boundaries. The decision negates the initial ban, questioning the Commission's risk management and EFSA's hazard versus risk assessment approaches.